Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2018

Open Access 01-03-2018 | General Gynecology

Association of endogenous circulating sex steroids and condition-specific quality of life domains in postmenopausal women with pelvic floor disorders

Authors: Barbara Bodner-Adler, Klaus Bodner, Oliver Kimberger, Ksenia Halpern, Heinz Koelbl, Wolfgang Umek

Published in: Archives of Gynecology and Obstetrics | Issue 3/2018

Login to get access

Abstract

Objective

To examine the relationship between endogenous sex steroids and various condition-specific quality of life domains in postmenopausal women with pelvic floor disorders. We hypothesized that woman with lowest androgen and estradiol concentrations would report worse scores of quality of life domains.

Methods

Forty-six women with pelvic organ prolapse (POP) and 47 cases with stress urinary incontinence (SUI) answered the validated pelvic floor questionnaire and underwent serum sex steroid measurement. A multivariate logistic regression model was used to determine the association between subjective outcome parameters and serum hormonal levels after adjusting for confounders.

Results

Univariate analysis revealed a strong inverse correlation between serum estradiol level (E2) and prolapse domain score (correlation coefficient = 0.005) as well as a significant positive correlation between SHBG level and prolapse domain score (correlation coefficient = 0.019) in cases with POP. Furthermore, the sex domain score showed a significant negative correlation with the androstendion (correlation coefficient = 0.020), DHEAS (correlation coefficient = 0.046) and testosterone level (correlation coefficient = 0.032) in the POP group. In the multivariate model, high serum SHBG (CI: 0.007–0.046) remained independently associated with worse scores in the prolapse domain and low serum DHEAS (CI: − 0.989 to 1.320) persisted as a significant predictor for a worse score in the sex domain. Regarding SUI cases, no association was noted between serum hormonal levels and quality of life related pelvic floor domains (correlation coefficient > 0.05).

Conclusion

Our results suggest that pelvic floor related quality of life might also be affected by endogenous sex steroids in POP, but not in SUI cases.
Literature
1.
go back to reference Rogers RG, Villareal A, Kammerer-Doak D, Qualls C (2001) Sexual function in women with and without urinary incontinence and/or pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 12:361–365CrossRefPubMed Rogers RG, Villareal A, Kammerer-Doak D, Qualls C (2001) Sexual function in women with and without urinary incontinence and/or pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct 12:361–365CrossRefPubMed
2.
go back to reference Thrall G, Lane D, Carroll D, Lip GY (2006) Quality of life with atrial fibrillation. A systematic review. Am J Med 119:e1–e19CrossRef Thrall G, Lane D, Carroll D, Lip GY (2006) Quality of life with atrial fibrillation. A systematic review. Am J Med 119:e1–e19CrossRef
3.
go back to reference Shumaker SA, Wyman JF, Uebersax JS, McCLish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact questionnaire and the urogenital distress inventory. Continence program in women (CPW) Research Group. Qual Life Res 3:291–306CrossRefPubMed Shumaker SA, Wyman JF, Uebersax JS, McCLish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact questionnaire and the urogenital distress inventory. Continence program in women (CPW) Research Group. Qual Life Res 3:291–306CrossRefPubMed
4.
go back to reference Sartori MG, Feldner PC, Jarmy-Di Bella ZI, Aquino Castro R, Baracat EC, Rodrigues de Lima G et al (2011) Sexual steroids in urogynecology. Climacteric 14(1):5–14CrossRefPubMed Sartori MG, Feldner PC, Jarmy-Di Bella ZI, Aquino Castro R, Baracat EC, Rodrigues de Lima G et al (2011) Sexual steroids in urogynecology. Climacteric 14(1):5–14CrossRefPubMed
5.
go back to reference Iosif CS, Batra S, Ek A, Astedt B (1981) Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 141(7):817–820CrossRefPubMed Iosif CS, Batra S, Ek A, Astedt B (1981) Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 141(7):817–820CrossRefPubMed
6.
go back to reference Robinson D, Cardozo LD (2003) The role of estrogens in female lower urinary tract dysfunction. Urology 62(4A):45–51CrossRefPubMed Robinson D, Cardozo LD (2003) The role of estrogens in female lower urinary tract dysfunction. Urology 62(4A):45–51CrossRefPubMed
8.
go back to reference Bai SW, Jung BH, Chung BC, Kim SU, Kim JY, Rha KH, Kim SK et al (2002) Steroid hormone metabolism in women with pelvic organ prolapse. J Reprod Med 47:303–308PubMed Bai SW, Jung BH, Chung BC, Kim SU, Kim JY, Rha KH, Kim SK et al (2002) Steroid hormone metabolism in women with pelvic organ prolapse. J Reprod Med 47:303–308PubMed
9.
go back to reference Smith P, Heimer G, Norgren A, Ulmsten U (1993) Localization of steroid hormone receptors in the pelvic muscles. Eur J Obstet Gynecol Reprod Biol 50:83–85CrossRefPubMed Smith P, Heimer G, Norgren A, Ulmsten U (1993) Localization of steroid hormone receptors in the pelvic muscles. Eur J Obstet Gynecol Reprod Biol 50:83–85CrossRefPubMed
10.
go back to reference Schoenfeld M, Fuermetz A, Muenster M, Ennemoser S, Bodungen V, Friese K, Jundt K (2013) Sexuality in German urogynecological patients and healthy controls: is there a difference with respect to diagnosis? Eur J Obest Gynecol Reprod Biol 170:567–570CrossRef Schoenfeld M, Fuermetz A, Muenster M, Ennemoser S, Bodungen V, Friese K, Jundt K (2013) Sexuality in German urogynecological patients and healthy controls: is there a difference with respect to diagnosis? Eur J Obest Gynecol Reprod Biol 170:567–570CrossRef
12.
go back to reference Baessler K, Junginger B (2011) Validation of a pelvic floor questionnaire with improvement and satisfaction scales to assess symptom severity, bothersomeness and quality of life before and after pelvic floor therapy. Aktuelle Urologie 42(5):316–322CrossRefPubMed Baessler K, Junginger B (2011) Validation of a pelvic floor questionnaire with improvement and satisfaction scales to assess symptom severity, bothersomeness and quality of life before and after pelvic floor therapy. Aktuelle Urologie 42(5):316–322CrossRefPubMed
13.
go back to reference Bodner-Adler B, Bodner K, Schneidinger C, Kimberger O, Halpern K, Koelbl H, Umek W (2017) Pelvic organ prolapse and endogenous circulating sex steroids in postmenopausal women: a case control-study. Eur J Obstet Gynecol Reprod Biol 210:177–181CrossRefPubMed Bodner-Adler B, Bodner K, Schneidinger C, Kimberger O, Halpern K, Koelbl H, Umek W (2017) Pelvic organ prolapse and endogenous circulating sex steroids in postmenopausal women: a case control-study. Eur J Obstet Gynecol Reprod Biol 210:177–181CrossRefPubMed
15.
16.
go back to reference Abrams P, Cardozoo L, Fall M, Griffiths D, Rosier P, Ulmsten U (2003) The standardization of terminology in lower urinary tract function: report from the standardization sub-committee of the International Incontinence Society. Urology 61:37–49CrossRefPubMed Abrams P, Cardozoo L, Fall M, Griffiths D, Rosier P, Ulmsten U (2003) The standardization of terminology in lower urinary tract function: report from the standardization sub-committee of the International Incontinence Society. Urology 61:37–49CrossRefPubMed
17.
go back to reference Haylen B, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26CrossRefPubMed Haylen B, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21:5–26CrossRefPubMed
18.
go back to reference Vergeldt TFM, Weemhoff M, Inthout J, Kluivers KB et al (2015) Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J 26:1559–1573CrossRefPubMedPubMedCentral Vergeldt TFM, Weemhoff M, Inthout J, Kluivers KB et al (2015) Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J 26:1559–1573CrossRefPubMedPubMedCentral
19.
go back to reference Kwon JK, Kim JH, Choi H, Chang IH, Park BR, Kwon SS, Lee ES et al (2014) Voiding characteristics and related hormonal changes in perimenopausal and postmenopausal women: a preliminary study. Maturitas 79(3):311–315CrossRefPubMed Kwon JK, Kim JH, Choi H, Chang IH, Park BR, Kwon SS, Lee ES et al (2014) Voiding characteristics and related hormonal changes in perimenopausal and postmenopausal women: a preliminary study. Maturitas 79(3):311–315CrossRefPubMed
20.
go back to reference Teleman PM, Persson J, Mattiasson A, Samsioe G (2009) The relationship between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women’s health in the Lund Area (WHILA) study. Acta Obst Gynecol Scnadinavica 88:927–932CrossRef Teleman PM, Persson J, Mattiasson A, Samsioe G (2009) The relationship between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women’s health in the Lund Area (WHILA) study. Acta Obst Gynecol Scnadinavica 88:927–932CrossRef
21.
go back to reference Monks DA, O’Bryant EL, Jordan CL (2004) Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction. J Comp Neurol 473(1):59–72CrossRefPubMed Monks DA, O’Bryant EL, Jordan CL (2004) Androgen receptor immunoreactivity in skeletal muscle: enrichment at the neuromuscular junction. J Comp Neurol 473(1):59–72CrossRefPubMed
22.
go back to reference Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA (1998) Androgens, estrogens, and second messengers. Steroids 63:278–281CrossRefPubMed Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA (1998) Androgens, estrogens, and second messengers. Steroids 63:278–281CrossRefPubMed
23.
go back to reference Nakhla AM, Leonard J, Hryb DJ, Rosner W (1999) Sex hormone-binding globulin receptor signal transduction proceeds via a G protein. Steroids 64:213–216CrossRefPubMed Nakhla AM, Leonard J, Hryb DJ, Rosner W (1999) Sex hormone-binding globulin receptor signal transduction proceeds via a G protein. Steroids 64:213–216CrossRefPubMed
24.
go back to reference Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84:3896–3902PubMed Barnhart KT, Freeman E, Grisso JA, Rader DJ, Sammel M, Kapoor S, Nestler JE (1999) The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life. J Clin Endocrinol Metab 84:3896–3902PubMed
Metadata
Title
Association of endogenous circulating sex steroids and condition-specific quality of life domains in postmenopausal women with pelvic floor disorders
Authors
Barbara Bodner-Adler
Klaus Bodner
Oliver Kimberger
Ksenia Halpern
Heinz Koelbl
Wolfgang Umek
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 3/2018
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-018-4650-7

Other articles of this Issue 3/2018

Archives of Gynecology and Obstetrics 3/2018 Go to the issue